ATE250673T1 - Verfahren zur identifizierung metastatischer sequenzen - Google Patents
Verfahren zur identifizierung metastatischer sequenzenInfo
- Publication number
- ATE250673T1 ATE250673T1 AT96942779T AT96942779T ATE250673T1 AT E250673 T1 ATE250673 T1 AT E250673T1 AT 96942779 T AT96942779 T AT 96942779T AT 96942779 T AT96942779 T AT 96942779T AT E250673 T1 ATE250673 T1 AT E250673T1
- Authority
- AT
- Austria
- Prior art keywords
- sequences
- cells
- metastatic
- probes
- cell line
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US683895P | 1995-11-16 | 1995-11-16 | |
| US08/594,031 US5783182A (en) | 1996-01-30 | 1996-01-30 | Method for identifying metastatic sequences |
| PCT/US1996/018567 WO1997018454A2 (en) | 1995-11-16 | 1996-11-15 | Method for identifying metastatic sequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE250673T1 true ATE250673T1 (de) | 2003-10-15 |
Family
ID=26676129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96942779T ATE250673T1 (de) | 1995-11-16 | 1996-11-15 | Verfahren zur identifizierung metastatischer sequenzen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0870057B1 (de) |
| AT (1) | ATE250673T1 (de) |
| AU (1) | AU725186B2 (de) |
| CA (1) | CA2237929A1 (de) |
| DE (1) | DE69630142D1 (de) |
| WO (1) | WO1997018454A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE38490E1 (en) | 1995-11-16 | 2004-04-06 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| USRE38392E1 (en) | 1996-01-30 | 2004-01-20 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| US6172211B1 (en) | 1997-07-11 | 2001-01-09 | Boehringer Ingelheim International Gmbh | Nucleic acid encoding tag7 polypeptide |
| US6277571B1 (en) | 1997-10-03 | 2001-08-21 | Virginia Commonwealth University Intellectual Property Foundation | Sequential consensus region-directed amplification of known and novel members of gene families |
| US6252058B1 (en) | 1997-11-05 | 2001-06-26 | Timothy C. Thompson | Sequences for targeting metastatic cells |
| EP1062340A2 (de) * | 1998-03-13 | 2000-12-27 | The Baylor College of Medicine | Zusammensetzungen und verfahren zur behandlung und prophylaxe der metastasen erkrankungen |
| AU6531101A (en) | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EP1188839A1 (de) * | 2000-09-19 | 2002-03-20 | EVOTEC Neurosciences GmbH | Verwendung von "Caveolae-Associated Integral " Membranprotein zur Diagnose und in Therapie von Alzheimer und verbundenen Neurodegenerativen Erkrankungen |
| CA2431861A1 (en) * | 2000-12-08 | 2002-06-13 | Curagen Corporation | Method of detecting and treating tuberous sclerosis complex associated disorders |
| US7157558B2 (en) | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
| US7462491B2 (en) | 2002-01-31 | 2008-12-09 | Baylor College Of Medicine | Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin |
| WO2004002516A1 (ja) * | 2002-06-28 | 2004-01-08 | Takeda Chemical Industries, Ltd. | 呼吸器疾患の診断・予防・治療剤 |
| EP1815016B1 (de) | 2004-11-01 | 2012-06-27 | George Mason University | Zusammensetzungen und verfahren zur diagnose von kolonerkrankungen |
| WO2008079972A2 (en) | 2006-12-20 | 2008-07-03 | Bayer Healthcare Llc | 4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer |
| CN103079567A (zh) | 2010-04-17 | 2013-05-01 | 拜尔健康护理有限责任公司 | 用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物 |
| EP3604534A1 (de) | 2011-02-11 | 2020-02-05 | The Rockefeller University | Verfahren zur identifizierung von nukleinsäuren, die die metastasierung regulieren |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1181234B (it) * | 1984-11-22 | 1987-09-23 | Giovanni Zago | Sistemi di pulizia automatica per videoregistratori e cassette di pulizia cosi' realizzate |
| AU5197986A (en) * | 1984-11-30 | 1986-06-18 | Whitehead Institute For Biomedical Research | Transmissible, mammalian genes associated with tumor metastasis |
| GB9311130D0 (en) * | 1993-05-28 | 1993-07-14 | Isis Innovation | Tumor metastasis gene |
| WO1995019369A1 (en) * | 1994-01-14 | 1995-07-20 | Vanderbilt University | Method for detection and treatment of breast cancer |
| US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
-
1996
- 1996-11-15 DE DE69630142T patent/DE69630142D1/de not_active Expired - Lifetime
- 1996-11-15 EP EP96942779A patent/EP0870057B1/de not_active Expired - Lifetime
- 1996-11-15 AU AU11609/97A patent/AU725186B2/en not_active Ceased
- 1996-11-15 WO PCT/US1996/018567 patent/WO1997018454A2/en not_active Ceased
- 1996-11-15 AT AT96942779T patent/ATE250673T1/de not_active IP Right Cessation
- 1996-11-15 CA CA002237929A patent/CA2237929A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997018454A3 (en) | 1997-08-14 |
| AU1160997A (en) | 1997-06-05 |
| AU725186B2 (en) | 2000-10-05 |
| DE69630142D1 (de) | 2003-10-30 |
| WO1997018454A2 (en) | 1997-05-22 |
| EP0870057A2 (de) | 1998-10-14 |
| CA2237929A1 (en) | 1997-05-22 |
| EP0870057B1 (de) | 2003-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69630142D1 (de) | Verfahren zur identifizierung metastatischer sequenzen | |
| MXPA02006145A (es) | Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina. | |
| DE69823347D1 (de) | Mikrofluidisches system und verfahren zu dessen betrieb | |
| DE60120151D1 (de) | Isolierung von mesenchymalen stammzellen und deren verwendung | |
| DE69824004D1 (de) | Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion | |
| DE3853678D1 (de) | Verfahren zum nachweis des karzinogenen menschlichen papillomavirus. | |
| TR199901667T2 (xx) | 3-Heterosiklil-ikame edilmi� benzoil t�revleri | |
| ATE224736T1 (de) | Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie | |
| DE60029369D1 (de) | Verfahren und Sondenset zur Erkennung von Krebs | |
| PT979308E (pt) | Metodo de preparacao de um padrao tipo de um transcrito genetico para diagnostico | |
| DE69918089D1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
| NO20002980D0 (no) | Universelt celleoppsamlingsmedium | |
| ATE182180T1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
| DE60333295D1 (de) | Verfahren zum nachweis abnormal methylierter nukleinsäure in heterogenen biologischen proben | |
| ATE365227T1 (de) | Endometriose marker und verwendung derselben | |
| DE60028544D1 (de) | Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs | |
| DE60142228D1 (de) | Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal | |
| WO1999046385A3 (en) | Compositions and methods for the treatment and prevention of metastatic disorders | |
| DE60326748D1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
| DE69632252D1 (de) | Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe | |
| ATE48140T1 (de) | Modifizierte nukleotide und verfahren zu ihrer herstellung und anwendung. | |
| DE60043775D1 (de) | Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern | |
| DE60044350D1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
| DE60024997D1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| DE69506704D1 (de) | Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |